These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 8558191)

  • 21. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
    Forastiere AA; Heitmiller RF; Lee DJ; Zahurak M; Abrams R; Kleinberg L; Watkins S; Yeo CJ; Lillemoe KD; Sitzmann JV; Sharfman W
    Cancer J Sci Am; 1997; 3(3):144-52. PubMed ID: 9161779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery .
    Gill PG; Denham JW; Jamieson GG; Devitt PG; Yeoh E; Olweny C
    J Clin Oncol; 1992 Jul; 10(7):1037-43. PubMed ID: 1607911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.
    Swisher SG; Moughan J; Komaki RU; Ajani JA; Wu TT; Hofstetter WL; Konski AA; Willett CG
    J Thorac Oncol; 2017 Feb; 12(2):368-374. PubMed ID: 27729298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
    Hirst J; Smithers BM; Gotley DC; Thomas J; Barbour A
    Ann Surg Oncol; 2011 Jun; 18(6):1766-74. PubMed ID: 21213056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer.
    Schneider BJ; Lee JS; Hayman JA; Chang AC; Orringer MB; Pickens A; Pan CC; Merajver SD; Urba SG
    Invest New Drugs; 2013 Apr; 31(2):435-42. PubMed ID: 22847786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.
    Adelstein DJ; Rice TW; Becker M; Larto MA; Kirby TJ; Koka A; Tefft M; Zuccaro G
    Cancer; 1997 Sep; 80(6):1011-20. PubMed ID: 9305700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative chemotherapy and radiotherapy for esophageal carcinoma.
    Naunheim KS; Petruska P; Roy TS; Andrus CH; Johnson FE; Schlueter JM; Baue AE
    J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
    Darnton SJ; Archer VR; Stocken DD; Mulholland PJ; Casson AG; Ferry DR
    J Clin Oncol; 2003 Nov; 21(21):4009-15. PubMed ID: 14581424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma.
    Suntharalingam M; Haas ML; Sonett JR; Doyle LA; Hausner PF; Schuetz J; Greenwald B; Krasna MJ
    Cancer J; 2001; 7(6):509-15. PubMed ID: 11769864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
    Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.
    O'Connor BM; Chadha MK; Pande A; Lombardo JC; Nwogu CE; Nava HR; Yang G; Javle MM
    Cancer J; 2007; 13(2):119-24. PubMed ID: 17476140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
    J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus.
    Jones DR; Detterbeck FC; Egan TM; Parker LA; Bernard SA; Tepper JE
    Ann Thorac Surg; 1997 Jul; 64(1):185-91; discussion 191-2. PubMed ID: 9236358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of surgery in multimodality therapy for esophageal cancer.
    Ebie N; Kang HJ; Millikan K; Murthy AK; Griem K; Hartsell W; Recine DC; Doolas A; Taylor S
    Am J Clin Oncol; 1997 Feb; 20(1):11-5. PubMed ID: 9020280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.